Q1. What is the business of Paras Healthcare?

Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.

Q2. Why is the company raising funds via IPO?

The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.

Q3. What is the size of the issue and where will it list?

The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale; shares will list on BSE and NSE.

Q5. What are the potential upsides?

Upsides include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.

Q6. How to apply for the IPO?

Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.

Paras Healthcare IPO: Price, Review, Detail

Upcoming

Paras Healthcare IPO: Price, Review, Detail

Market Cap

IPO Issue Size

₹ 400 crore + 4,974,010 Shares

Expected Price by IPOCorner

IPO Score

*Score varies on actual price

Founded in 2006, Paras Healthcare operates a network of multi-specialty tertiary hospitals across North and East India, focusing on making advanced medical care accessible and affordable.
The company’s IPO aims to raise approximately ₹400 crore via a fresh issue along with an offer-for-sale component, providing investors an opportunity to participate in India’s growing healthcare sector.

The company was incorporated on December 21, 1987,The Managing Director is Dr. Dharminder Kumar Nagar (also a promoter), who has spearheaded the company’s expansion since its inception.

Paras Healthcare Limited delivers specialised tertiary medical care services—covering cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and joint replacement—primarily in underserved Tier-II and Tier-III cities.

Subscription date to apply for Paras Healthcare TBA. Price band for the IPO is TBA.

₹ 400 crore + 4,974,010 Shares

Fresh Issue

₹ 400 Crore

Offer for Sale

14,974,010 Equity shares

Year	2024
Networth	~ ₹ 338.50 Cr
Revenue	~ ₹ 1129.03 Cr
EBITDA	~ ₹ 154.41 Cr
PAT	~ ₹ -15.33 Cr
EBITDA Margin	~ 13.68%
PAT Margin	-1.36%
Face Value	Rs.01 per Equity Share

IPO Important Dates

#	Date
Open Date	TBA
Close Date	TBA
Anchor Investor Bidding	TBA
Allotment Date	TBA
Refunds& Demat Credit	TBA
Tentative Listing Date	TBA

Use Of Proceeds

Purpose	Amount

Financial Data

#	2022	2023	2024
Revenue (₹ Cr)	₹ 779.9	₹ 917.9	₹ 1,129.0
PAT (₹ Cr)	₹ -14.8	₹ -42.8	₹ -15.3
Asset (₹ Cr)	₹ 963.5	₹ 1,293.1	₹ 1,477.7
Net Worth (₹ Cr)	₹ 73.1	₹ 30.1	₹ 338.5

IPO Grey Market Premium

Date	IPO Price	IPO GMP	Profit Per Lot
17-Jun	₹ –	₹ –	₹ –
16-Jun	₹ –	₹ –	₹ –
15-Jun	₹ –	₹ –	₹ –
14-Jun	₹ –
13-Jun	₹ –

Pros

Strong presence in North & East India with growing hospital network.
Focus on underserved Tier-II & Tier-III cities.
Consistent revenue growth and improving margins.
Expansion in high-demand healthcare segments.
Experienced management with proven operational track record.

Cons

Loss-making company with negative PAT.
High competition from established hospital chains.
Rising operational and finance costs.
Heavy dependence on a few key hospitals.
Regulatory and compliance risks in healthcare sector.

Promoters – Pre offer equity (Approx)

Promoters	% Shares
Dr. Dharminder Kumar Nagar	~75.32%
Commelina Ltd.	~24.68%
-	-
-	-
-	-
-	-

Lot Size details

Application Type	Lot Size	No. of Lot	No. of Shares	Investment Amount
Retail (Min)	–	1	–	₹ –
Retail (Max)	–	13	–	₹ –
HNI (Min)	–	14	–	₹ –
HNI (Max)	–	66	–	₹ –
Big HNI (Min)	–	67	–	₹ –

Key Performance Index (KPI)

ROE	00
ROCE	00
RoNW	00

Lead / Book Running Lead Managers

ICICI Securities Limited IIFL Securities Limited Motilal Oswal Investment Advisors Limited

Registrar (RTA)

Link Intime India Private Limited

Q1. What is the business of Paras Healthcare?
Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.
Q2. Why is the company raising funds via IPO?
The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.
Q3. What is the size of the issue and where will it list?
The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale; shares will list on BSE and NSE.
Q5. What are the potential upsides?
Upsides include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.
Q6. How to apply for the IPO?
Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.